Deciphera Pharmaceuticals, Llc
Clinical trials sponsored by Deciphera Pharmaceuticals, Llc, explained in plain language.
-
New hope for Hard-to-Treat GIST: experimental drug DCC-3009 enters human trials
Disease control Recruiting nowThis study tests an experimental drug called DCC-3009, alone or with other cancer treatments, in people with advanced gastrointestinal stromal tumor (GIST) that has stopped responding to standard therapies. The trial has two parts: first, finding the safest dose, then checking ho…
Phase: PHASE1, PHASE2 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New study tracks Real-Life use of TGCT drug vimseltinib
Knowledge-focused Recruiting nowThis study observes 100 people with tenosynovial giant cell tumor (TGCT) who are taking vimseltinib as part of their normal care. Researchers will track how long patients stay on the drug and how their quality of life changes. No extra treatments or tests are given—just real-worl…
Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:05 UTC